Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.97 USD | -0.43% | +919.65% | +25.84% |
Sales 2024 * | 39.35M 3.09B | Sales 2025 * | 58.17M 4.57B | Capitalization | 70.86M 5.57B |
---|---|---|---|---|---|
Net income 2024 * | -120M -9.43B | Net income 2025 * | -77M -6.05B | EV / Sales 2024 * | -1.44 x |
Net cash position 2024 * | 127M 10.01B | Net cash position 2025 * | 54.53M 4.28B | EV / Sales 2025 * | 0.28 x |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-1.24
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -0.43% | ||
1 week | +919.65% | ||
Current month | +894.25% | ||
1 month | +857.58% | ||
3 months | +46.12% | ||
6 months | +129.76% | ||
Current year | +25.84% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 04/09/18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 11/04/21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 05/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 30/11/08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 04/09/18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 11/12/19 |
Date | Price | Change | Volume |
---|---|---|---|
22/05/24 | 1.371 | +4.51% | 7,626 |
21/05/24 | 1.312 | -3.53% | 400 |
20/05/24 | 1.36 | +2.98% | 112 |
17/05/24 | 1.321 | +0.71% | 6,216 |
16/05/24 | 1.311 | -4.28% | 6,927 |
Delayed Quote London S.E., February 04, 2021 at 02:50 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.74% | 723B | |
+34.68% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.03% | 244B | |
+10.04% | 208B | |
-4.13% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- MRNS Stock
- 0JYL Stock